Search Within

Sandra Pierina D'Angelo

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (5)
  3. Research Letter (1)
Groups
  1. Department of Medicine (13)
  2. Gastrointestinal Oncology Service (13)
  3. Hematologic Malignancies, Division of (13)
  4. Sarcoma Service (13)
  5. Solid Tumor Oncology Division (13)
  6. GSK Faculty (11)

More Groups

People
  1. Jedd Wolchok (8)
  2. James Harding (6)
  3. Mark Dickson (6)
  4. Michael Postow (6)
  5. Paul Chapman (6)
  6. Gary Schwartz (5)

More People

Years
  1. 2019 (2)
  2. 2017 (1)
  3. 2016 (1)
  4. 2013 (3)
  5. 2012 (3)
  6. 2011 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Journal of Thoracic Oncology (3)
  3. Cancer (1)
  4. Cancer Immunology Research (1)
  5. Nature Genetics (1)
  6. Pigment Cell & Melanoma Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (3)
  3. Wiley Blackwell (2)
  4. American Association for Cancer Research (1)
  5. Nature Publishing Group (1)
  6. Oxford University Press (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Patient perspectives on ipilimumab across the melanoma treatment trajectory
    Journal Article

    Shuk, E.; Shoushtari, A. N.; Luke, J.; Postow, M. A.; Callahan, M.; Harding, J. J.; Roth, K. G.; Flavin, M.; Granobles, A.; Christian, J.; more...
    Supportive Care in Cancer (2017)

    Fulltext@MSK | Save
  • Autoimmune bullous skin disorders with immune checkpoint inhibitors targeting PD-1 and PD-L1
    Journal Article

    Naidoo, J.; Schindler, K.; Querfeld, C.; Busam, K.; Cunningham, J.; Page, D. B.; Postow, M. A.; Weinstein, A.; Lucas, A. S.; Ciccolini, K. T.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience
    Journal Article

    Luke, J. J.; Callahan, M. K.; Postow, M. A.; Romano, E.; Ramaiya, N.; Bluth, M.; Giobbie-Hurder, A.; Lawrence, D. P.; Ibrahim, N.; Ott, P. A.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Ipilimumab for patients with advanced mucosal melanoma
    Journal Article

    Postow, M. A.; Luke, J. J.; Bluth, M. J.; Ramaiya, N.; Panageas, K. S.; Lawrence, D. P.; Ibrahim, N.; Flaherty, K. T.; Sullivan, R. J.; Ott, P. A.; more...
    The Oncologist (2013)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Infliximab (IFX) for ipilimumab (IPI)-induced colitis in melanoma patients (pts)
    Meeting Abstract

    Harding, J. J.; Callahan, M.; Postow, M.; Rocco, K.; D'Angelo, S.; Dickson, M.; Carvajal, R.; Schwartz, G. K.; Wolchok, J.; Chapman, P.
    Pigment Cell & Melanoma Research (2012)

    Fulltext@MSK | Save
  • Distinct clinical course of EGFR-mutant resected lung cancers: Results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib
    Journal Article

    D'Angelo, S. P.; Janjigian, Y. Y.; Ahye, N.; Riely, G. J.; Chaft, J. E.; Sima, C. S.; Shen, R.; Zheng, J.; Dycoco, J.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save